Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences

Nucleic Acids Research

Volumn 37, Issue 5, 2009, Pages 1486-1500

  Brázdová, Marie ^a,b   Quante, Timo ^a   Tögel, Lars ^a   Walter, Korden ^a,c   Loscher, Christine ^a   Tichý, Vlastimil ^b   Činčárová, Lenka ^b   Deppert, Wolfgang ^a   Tolstonog, Genrich V ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FRMD5; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FRAGMENTATION; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE BINDING SITE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

BINDING SITES; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA, INTERGENIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; INTRONS; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 63549149651     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn1085     Document Type: Article

References (80)

1. Soussi,T., Kato,S., Levy,P.P. and Ishioka,C. (2005) Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum. Mutat., 25, 6-17.
2. Petitjean,A., Mathe,E., Kato,S., Ishioka,C., Tavtigian,S.V., Hainaut,P. and Olivier,M. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum. Mutat., 28, 622-629.
3. Petitjean,A., Achatz,M.I., Borresen-Dale,A.L., Hainaut,P. and Olivier,M. (2007) TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene, 26, 2157-2165.
4. Ma,B. and Levine,A.J. (2007) Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements. Nucleic Acids Res., 35, 7733-7747.
5. Ang,H.C., Joerger,A.C., Mayer,S. and Fersht,A.R. (2006) Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains. J. Biol. Chem., 281, 21934-21941.
6. Gohler,T., Jager,S., Warnecke,G., Yasuda,H., Kim,E. and Deppert,W. (2005) Mutant p53 proteins bind DNA in a DNA structure-selective mode. Nucleic Acids Res., 33, 1087-1100.
7. Kim,E. and Deppert,W. (2004) Transcriptional activities of mutant p53: when mutations are more than a loss. J. Cell Biochem., 93, 878-886.
8. Weisz,L., Oren,M. and Rotter,V. (2007) Transcription regulation by mutant p53. Oncogene, 26, 2202-2211.
9. Chicas,A., Molina,P. and Bargonetti,J. (2000) Mutant p53 forms a complex with Sp1 on HIV-LTR DNA. Biochem. Biophys. Res. Commun., 279 383-390.
10. Xu,D., Wilson,T.J., Chan,D., De Luca,E., Zhou,J., Hertzog,P.J. and Kola,I. (2002) Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J., 21, 4081-4093.
11. Di Agostino,S., Strano,S., Emiliozzi,V., Zerbini,V., Mottolese,M., Sacchi,A., Blandino,G. and Piaggio,G. (2006) Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell, 10, 191-202.
12. Menendez,D., Inga,A. and Resnick,M.A. (2006) The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol. Cell Biol., 26, 2297-2308.
13. Matas,D., Sigal,A., Stambolsky,P., Milyavsky,M., Weisz,L., Schwartz,D., Goldfinger,N. and Rotter,V. (2001) Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis. EMBO J., 20, 4163-4172.
14. Frazier,M.W., He,X., Wang,J., Gu,Z., Cleveland,J.L. and Zambetti,G.P. (1998) Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol. Cell Biol., 18, 3735-3743.
15. Espinosa,J.M. and Emerson,B.M. (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell, 8, 57-69.
16. Liu,W.L., Midgley,C., Stephen,C., Saville,M. and Lane,D.P. (2001) Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein. J. Mol. Biol., 313, 711-731.
17. Istrail,S. and Davidson,E.H. (2005) Logic functions of the genomic cis-regulatory code. Proc. Natl Acad. Sci. USA, 102, 4954-4959.
18. de Laat,W. and Grosveld,F. (2003) Spatial organization of gene expression: The active chromatin hub. Chromosome Res., 11, 447-459.
19. Gaszner,M. and Felsenfeld,G. (2006) Insulators: Exploiting transcriptional and epigenetic mechanisms. Nat. Rev. Genet., 7 703-713.
20. Li,Q., Peterson,K.R., Fang,X. and Stamatoyannopoulos,G. (2002) Locus control regions. Blood, 100, 3077-3086.
21. West,A.G. and Fraser,P. (2005) Remote control of gene transcription. Hum Mol Genet, 14, R101-R111.
22. Gluch,A., Vidakovic,M. and Bode,J. (2008) Scaffold/matrix attachment regions (S/MARs): Relevance for disease and therapy. Handb. Exp. Pharmacol., 186, 67-103.
23. Razin,S.V., Gromova,II and Iarovaia,O.V. (1995) Specificity and functional significance of DNA interaction with the nuclear matrix: New approaches to clarify the old questions. Int. Rev. Cytol., 162B 405-448.
24. Berezney,R., Mortillaro,M.J., Ma,H., Wei,X. and Samarabandu,J. (1995) The nuclear matrix: A structural milieu for genomic function. Int. Rev. Cytol., 162A, 1-65.
25. Bode,J., Winkelmann,S., Gotze,S., Spiker,S., Tsutsui,K., Bi,C., A,K.P. and Benham,C. (2006) Correlations between scaffold/matrix attachment region (S/MAR) binding activity and DNA duplex destabilization energy. J. Mol. Biol., 358, 597-613.
26. Koga,H. and Deppert,W. (2000) Identification of genomic DNA sequences bound by mutant p53 protein (Gly245->Ser) in vivo. Oncogene, 19 4178-4183.
27. Deppert,W. (1996) Binding of MAR-DNA elements by mutant p53: Possible implications for its oncogenic functions. J. Cell Biochem., 62 172-180.
28. Weissker,S.N., Muller,B.F., Homfeld,A. and Deppert,W. (1992) Specific and complex interactions of murine p53 with DNA. Oncogene, 7 1921-1932.
29. Will,K., Warnecke,G., Albrechtsen,N., Boulikas,T. and Deppert,W. (1998) High affinity MAR-DNA binding is a common property of murine and human mutant p53. J. Cell Biochem., 69, 260-270.
30. Will,K, Warnecke,G., Wiesmuller,L. and Deppert,W. (1998) Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing. Proc. Natl Acad. Sci. USA, 95, 13681-13686.
31. Orlando,V., Strutt,H. and Paro,R. (1997) Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods, 11, 205-214.
32. Tolstonog,G.V., Mothes,E., Shoeman,R.L. and Traub,P. (2001) Isolation of SDS-stable complexes of the intermediate filament protein vimentin with repetitive, mobile, nuclear matrix attachment region, and mitochondrial DNA sequence elements from cultured mouse and human fibroblasts. DNA Cell Biol., 20, 531-554.
33. Brummelkamp,T.R., Bernards,R. and Agami,R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553.
34. Chen,C., Ridzon,D.A., Broomer,A.J., Zhou,Z., Lee,D.H., Nguyen,J.T., Barbisin,M., Xu,N.L., Mahuvakar,V.R., Andersen,M.R. et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res., 33, e179.
35. Kent,W.J. (2002) BLAT-the BLAST-like alignment tool. Genome Res., 12, 656-664.
36. Halees,A.S. and Weng,Z. (2004) PromoSer: Improvements to the algorithm, visualization and accessibility. Nucleic Acids Res., 32, W191-W194.
37. Hackl,H., Burkard,T.R., Sturn,A., Rubio,R., Schleiffer,A., Tian,S., Quackenbush,J., Eisenhaber,F. and Trajanoski,Z. (2005) Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. Genome Biol., 6, R108.
38. Singh,G.B., Kramer,J.A. and Krawetz,S.A. (1997) Mathematical model to predict regions of chromatin attachment to the nuclear matrix. Nucleic Acids Res., 25, 1419-1425.
39. Thomas-Chollier,M., Sand,O., Turatsinze,J.V., Janky,R., Defrance,M., Vervisch,E., Brohee,S. and van Helden,J. (2008) RSAT: Regulatory sequence analysis tools. Nucleic Acids Res., 36, W119-W127.
40. Grillo,G., Licciulli,F., Liuni,S., Sbisa,E. and Pesole,G. (2003) PatSearch: A program for the detection of patterns and structural motifs in nucleotide sequences. Nucleic Acids Res., 31, 3608-3612.
41. Brazdova,M., Palecek,J., Cherny,D.I., Billova,S., Fojta,M., Pecinka,P., Vojtesek,B., Jovin,T.M. and Palecek,E. (2002) Role of tumor suppressor p53 domains in selective binding to supercoiled DNA. Nucleic Acids Res., 30, 4966-4974.
42. Schmittgen,T.D. and Livak,K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
43. Britanova,O., Akopov,S., Lukyanov,S., Gruss,P. and Tarabykin,V. (2005) Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur. J. Neurosci., 21, 658-668.
44. Nickerson,J.A., Krockmalnic,G., Wan,K.M. and Penman,S. (1997) The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proc. Natl Acad. Sci. USA, 94, 4446-4450.
45. He,S., Dunn,K.L., Espino,P.S., Drobic,B., Li,L., Yu,J., Sun,J.M., Chen,H.Y., Pritchard,S. and Davie,J.R. (2008) Chromatin organization and nuclear microenvironments in cancer cells. J. Cell Biochem., 104, 2004-2015.
46. Carter,D.R., Eskiw,C. and Cook,P.R. (2008) Transcription factories. Biochem. Soc. Trans., 36, 585-589.
47. Stein,G.S., Lian,J.B., van Wijnen,A.J., Stein,J.L., Javed,A., Montecino,M., Zaidi,S.K., Young,D., Choi,J.Y., Gutierrez,S. et al. (2004) Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation. J. Cell Biochem., 91, 287-302.
48. van Wijnen,A.J., Bidwell,J.P., Fey,E.G., Penman,S., Lian,J.B., Stein,J.L. and Stein,G.S. (1993) Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/ EBP, OCT-1, and AP-1. Biochemistry, 32, 8397-8402.
49. Guo,B., Odgren,P.R., van Wijnen,A.J., Last,T.J., Nickerson,J., Penman,S., Lian,J.B., Stein,J.L. and Stein,G.S. (1995) The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl Acad. Sci. USA, 92, 10526-10530.
50. Koutsodontis,G., Vasilaki,E., Chou,W.C., Papakosta,P. and Kardassis,D. (2005) Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem. J., 389, 443-455.
51. Sui,G., Affar el,B., Shi,Y., Brignone,C., Wall,N.R., Yin,P., Donohoe,M., Luke,M.P., Calvo,D. and Grossman,S.R. (2004) Yin Yang 1 is a negative regulator of p53. Cell, 117, 859-872.
52. Guelen,L., Pagie,L., Brasset,E., Meuleman,W., Faza,M.B., Talhout,W., Eussen,B.H., de Klein,A., Wessels,L., de Laat,W. et al. (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature, 453, 948-951.
53. Luderus,M.E., de Graaf,A., Mattia,E., den Blaauwen,J.L., Grande,M.A., de Jong,L. and van Driel,R. (1992) Binding of matrix attachment regions to lamin B1. Cell, 70, 949-959.
54. Hearnes,J.M., Mays,D.J., Schavolt,K.L., Tang,L., Jiang,X. and Pietenpol,J.A. (2005) Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators. Mol. Cell Biol., 25, 10148-10158.
55. Wei,C.L., Wu,Q., Vega,V.B., Chiu,K.P., Ng,P., Zhang,T., Shahab,A., Yong,H.C., Fu,Y., Weng,Z. et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell, 124, 207-219.
56. Greig,G.M. and Willard,H.F. (1992) Beta satellite DNA: Characterization and localization of two subfamilies from the distal and proximal short arms of the human acrocentric chromosomes. Genomics, 12, 573-580.
57. Eichler,E.E., Hoffman,S.M., Adamson,A.A., Gordon,L.A., McCready,P., Lamerdin,J.E. and Mohrenweiser,H.W. (1998) Complex beta-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12. Genome Res., 8, 791-808.
58. Sbisa,E., Catalano,D., Grillo,G., Licciulli,F., Turi,A., Liuni,S., Pesole,G., De Grassi,A., Caratozzolo,M.F., D'Erchia,A.M. et al. (2007) p53FamTaG: A database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinformatics, 8(Suppl 1), S20.
59. Frank-Kamenetskii,M.D. and Mirkin,S.M. (1995) Triplex DNA structures. Annu. Rev. Biochem., 64, 65-95.
60. Mazur,S.J., Sakaguchi,K., Appella,E., Wang,X.W., Harris,C.C. and Bohr,V.A. (1999) Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain. J. Mol. Biol., 292, 241-249.
61. Palecek,E., Brazda,V., Jagelska,E., Pecinka,P., Karlovska,L. and Brazdova,M. (2004) Enhancement of p53 sequence-specific binding by DNA supercoiling. Oncogene, 23, 2119-2127.
62. Chen,J. and Sadowski,I. (2005) Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc. Natl Acad. Sci. USA, 102, 4813-4818.
63. Reczek,E.E., Flores,E.R., Tsay,A.S., Attardi,L.D. and Jacks,T. (2003) Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol. Cancer Res., 1, 1048-1057.
64. Zauberman,A., Flusberg,D., Haupt,Y., Barak,Y. and Oren,M. (1995) A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res., 23, 2584-2592.
65. Lin,J., Wu,P.H., Tarr,P.T., Lindenberg,K.S., St-Pierre,J., Zhang,C.Y., Mootha,V.K., Jager,S., Vianna,C.R., Reznick,R.M. et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119, 121-135.
66. Joerger,A.C., Ang,H.C., Veprintsev,D.B., Blair,C.M. and Fersht,A.R. (2005) Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations. J. Biol. Chem., 280, 16030-16037.
67. Hinow,P., Rogers,C.E., Barbieri,C.E., Pietenpol,J.A., Kenworthy,A.K. and DiBenedetto,E. (2006) The DNA binding activity of p53 displays reaction-diffusion kinetics. Biophys. J., 91, 330-342.
68. Mueller,F., Wach,P. and McNally,J.G. (2008) Evidence for a common mode of transcription factor interaction with chromatin as revealed by improved quantitative fluorescence recovery after photobleaching. Biophys. J., 94, 3323-3339.
69. Xiao,H., Pearson,A., Coulombe,B., Truant,R., Zhang,S., Regier,J.L., Triezenberg,S.J., Reinberg,D., Flores,O., Ingles,C.J. et al. (1994) Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell Biol., 14, 7013-7024.
70. Jurka,J., Kapitonov,V.V., Kohany,O. and Jurka,M.V. (2007) Repetitive sequences in complex genomes: Structure and evolution. Annu. Rev. Genomics Hum. Genet., 8, 241-259.
71. Zuckerkandl,E. and Cavalli,G. (2007) Combinatorial epigenetics, 'junk DNA', and the evolution of complex organisms. Gene, 390, 232-242.
72. Hanke,J.H., Hambor,J.E. and Kavathas,P. (1995) Repetitive Alu elements form a cruciform structure that regulates the function of the human CD8 alpha T cell-specific enhancer. J. Mol. Biol., 246, 63-73.
73. Howell,R. and Usdin,K. (1997) The ability to form intrastrand tetraplexes is an evolutionarily conserved feature of the 3′ end of L1 retrotransposons. Mol. Biol. Evol., 14, 144-155.
74. Li,X.Y., MacArthur,S., Bourgon,R., Nix,D., Pollard,D.A., Iyer,V.N., Hechmer,A., Simirenko,L., Stapleton,M., Luengo Hendriks,C.L. et al. (2008) Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm. PLoS Biol., 6, e27.
75. Jackson,D.A. (2003) The principles of nuclear structure. Chromosome Res., 11, 387-401.
76. Cremer,T. and Cremer,C. (2001) Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2, 292-301.
77. Jiang,W.G., Douglas-Jones,A. and Mansel,R.E. (2003) Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int. J. Cancer, 106, 752-757.
78. Olivier,M., Langerod,A., Carrieri,P., Bergh,J., Klaar,S., Eyfjord,J., Theillet,C., Rodriguez,C., Lidereau,R., Bieche,I. et al. (2006) The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin. Cancer Res., 12, 1157-1167.
79. Bossi,G., Marampon,F., Maor-Aloni,R., Zani,B., Rotter,V., Oren,M., Strano,S., Blandino,G. and Sacchi,A. (2008) Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy. Cell Cycle, 7, 1870-1879.
80. Heinlein,C., Krepulat,F., Lohler,J., Speidel,D., Deppert,W. and Tolstonog,G.V. (2008) Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Int. J. Cancer, 122, 1701-1709.